New metabolizable immunologic adjuvant for human use. IX. Large-scale trials with multiple lots in different regimens.
D000276:Adjuvants, Immunologic / Q000009:adverse effects / Q000494:pharmacology*; D000293:Adolescent; D000328:Adult; D000368:Aged; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation / Q000187:drug effects*; D002648:Child; D002986:Clinical Trials as Topic; D005334:Fever / Q000209:etiology; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007252:Influenza Vaccines; D008875:Middle Aged; D013997:Time Factors; D014611:Vaccination
D000276:Adjuvants, Immunologic; D000906:Antibodies; D007252:Influenza Vaccines